135 related articles for article (PubMed ID: 36863479)
21. Aberrant expression of transforming growth factor beta-1 (TGF beta-1) per se does not discriminate fibrotic from non-fibrotic chronic myeloproliferative disorders.
Bock O; Loch G; Schade U; von Wasielewski R; Schlué J; Kreipe H
J Pathol; 2005 Apr; 205(5):548-57. PubMed ID: 15726648
[TBL] [Abstract][Full Text] [Related]
22. Transforming growth factor-beta and megakaryocytes in the pathogenesis of idiopathic myelofibrosis.
Martyré MC; Romquin N; Le Bousse-Kerdiles MC; Chevillard S; Benyahia B; Dupriez B; Demory JL; Bauters F
Br J Haematol; 1994 Sep; 88(1):9-16. PubMed ID: 7803262
[TBL] [Abstract][Full Text] [Related]
23. Elevated levels of basic fibroblast growth factor in megakaryocytes and platelets from patients with idiopathic myelofibrosis.
Martyré MC; Le Bousse-Kerdiles MC; Romquin N; Chevillard S; Praloran V; Demory JL; Dupriez B
Br J Haematol; 1997 May; 97(2):441-8. PubMed ID: 9163611
[TBL] [Abstract][Full Text] [Related]
24. Emperipolesis of neutrophils by dysmorphic megakaryocytes.
Parmley RT; Kim TH; Austin RL; Alvarado CS; Ragab AH
Am J Hematol; 1982 Dec; 13(4):303-11. PubMed ID: 7158625
[TBL] [Abstract][Full Text] [Related]
25. A pathobiologic pathway linking thrombopoietin, GATA-1, and TGF-beta1 in the development of myelofibrosis.
Vannucchi AM; Bianchi L; Paoletti F; Pancrazzi A; Torre E; Nishikawa M; Zingariello M; Di Baldassarre A; Rana RA; Lorenzini R; Alfani E; Migliaccio G; Migliaccio AR
Blood; 2005 May; 105(9):3493-501. PubMed ID: 15665119
[TBL] [Abstract][Full Text] [Related]
26. The effects of acrylamide on the frequency of megakaryocytic emperipolesis and the mitotic activity of rat bone marrow cells.
Yener Y; Dikmenli M
J Sci Food Agric; 2011 Aug; 91(10):1810-3. PubMed ID: 21452172
[TBL] [Abstract][Full Text] [Related]
27. [Emperipolesis in megakaryocytes in patients with thrombocytosis in the course of myeloproliferative disorders].
Bobik R; Podolak-Dawidziak M; Kiełbiński M; Jeleń M; Wróbel T
Acta Haematol Pol; 1995; 26(2):179-83. PubMed ID: 7653223
[TBL] [Abstract][Full Text] [Related]
28. Abnormalities of GATA-1 in megakaryocytes from patients with idiopathic myelofibrosis.
Vannucchi AM; Pancrazzi A; Guglielmelli P; Di Lollo S; Bogani C; Baroni G; Bianchi L; Migliaccio AR; Bosi A; Paoletti F
Am J Pathol; 2005 Sep; 167(3):849-58. PubMed ID: 16127162
[TBL] [Abstract][Full Text] [Related]
29. Pathogenesis of myelofibrosis with myeloid metaplasia.
Tefferi A
J Clin Oncol; 2005 Nov; 23(33):8520-30. PubMed ID: 16293880
[TBL] [Abstract][Full Text] [Related]
30. GATA1-defective immune-megakaryocytes as possible drivers of idiopathic pulmonary fibrosis.
Gobbo F; Zingariello M; Verachi P; Falchi M; Arciprete F; Martelli F; Peli A; Mazzarini M; Vierstra J; Mead-Harvey C; Dueck AC; Sarli G; Nava S; Sgalla G; Richeldi L; Migliaccio AR
bioRxiv; 2023 Sep; ():. PubMed ID: 37425686
[TBL] [Abstract][Full Text] [Related]
31. [TGF-beta and platelet].
Kogawa K; Mogi Y; Morii K; Takimoto R; Niitsu Y
Rinsho Ketsueki; 1994 Apr; 35(4):370-5. PubMed ID: 8028182
[TBL] [Abstract][Full Text] [Related]
32. Characterization of the TGF-β1 signaling abnormalities in the Gata1low mouse model of myelofibrosis.
Zingariello M; Martelli F; Ciaffoni F; Masiello F; Ghinassi B; D'Amore E; Massa M; Barosi G; Sancillo L; Li X; Goldberg JD; Rana RA; Migliaccio AR
Blood; 2013 Apr; 121(17):3345-63. PubMed ID: 23462118
[TBL] [Abstract][Full Text] [Related]
33. Altered SDF-1/CXCR4 axis in patients with primary myelofibrosis and in the Gata1 low mouse model of the disease.
Migliaccio AR; Martelli F; Verrucci M; Migliaccio G; Vannucchi AM; Ni H; Xu M; Jiang Y; Nakamoto B; Papayannopoulou T; Hoffman R
Exp Hematol; 2008 Feb; 36(2):158-71. PubMed ID: 18206727
[TBL] [Abstract][Full Text] [Related]
34. Emperipolesis of marrow cells within megakaryocytes in the bone marrow of sublethally irradiated mice.
Bobik R; Dabrowski Z
Ann Hematol; 1995 Feb; 70(2):91-5. PubMed ID: 7880931
[TBL] [Abstract][Full Text] [Related]
35. GATA1 downregulation in prefibrotic and fibrotic stages of primary myelofibrosis and in the myelofibrotic progression of other myeloproliferative neoplasms.
Sangiorgio VFI; Nam A; Chen Z; Orazi A; Tam W
Leuk Res; 2021 Jan; 100():106495. PubMed ID: 33360878
[TBL] [Abstract][Full Text] [Related]
36. The thrombopoietin/MPL axis is activated in the Gata1
Zingariello M; Sancillo L; Martelli F; Ciaffoni F; Marra M; Varricchio L; Rana RA; Zhao C; Crispino JD; Migliaccio AR
Blood Cancer J; 2017 Jun; 7(6):e572. PubMed ID: 28622305
[TBL] [Abstract][Full Text] [Related]
37.
Martelli F; Verachi P; Zingariello M; Mazzarini M; Vannucchi AM; Lonetti A; Bacci B; Sarli G; Migliaccio AR
Front Genet; 2021; 12():720552. PubMed ID: 34707640
[TBL] [Abstract][Full Text] [Related]
38. The frequency and significance of megakaryocytic emperipolesis in myeloproliferative and reactive states.
Cashell AW; Buss DH
Ann Hematol; 1992 Jun; 64(6):273-6. PubMed ID: 1637881
[TBL] [Abstract][Full Text] [Related]
39. Combined anti CXC receptors 1 and 2 therapy is a promising anti-inflammatory treatment for respiratory diseases by reducing neutrophil migration and activation.
Planagumà A; Domènech T; Pont M; Calama E; García-González V; López R; Aulí M; López M; Fonquerna S; Ramos I; de Alba J; Nueda A; Prats N; Segarra V; Miralpeix M; Lehner MD
Pulm Pharmacol Ther; 2015 Oct; 34():37-45. PubMed ID: 26271598
[TBL] [Abstract][Full Text] [Related]
40. Tetraspanin CD9 participates in dysmegakaryopoiesis and stromal interactions in primary myelofibrosis.
Desterke C; Martinaud C; Guerton B; Pieri L; Bogani C; Clay D; Torossian F; Lataillade JJ; Hasselbach HC; Gisslinger H; Demory JL; Dupriez B; Boucheix C; Rubinstein E; Amsellem S; Vannucchi AM; Le Bousse-Kerdilès MC
Haematologica; 2015 Jun; 100(6):757-67. PubMed ID: 25840601
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]